Cumulative Research Indicates Huperzine A Offers Potential Advantages Over AChE Inhibitors Used in U.S. to Treat Alzheimer's, Neuro-Hite

Cumulative Research Indicates Huperzine A Offers Potential Advantages Over AChE Inhibitors Used in U.S. to Treat Alzheimer's, Neuro-Hitech Study Finds: "umulative research on the development of huperzine A -- an alkaloid extract of the plant Huperzia serrata -- as a treatment for Alzheimer's shows it may have advantages over other AChE inhibitors being used in the U.S. to treat Alzheimer's Disease (AD), according to early results in a new study from Neuro-Hitech (OTCBB: NHPI),"

A phase II study is currently underway.